Las lesiones inflamatorias, el picor y otros síntomas que caracterizan estas enfermedades pueden provocar ansiedad, ...
STAMFORD, Conn., March 28, 2022 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), an early commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of ...
– Oral difelikefalin as adjunct to topical corticosteroids (TCS) did not demonstrate meaningful clinical benefit compared to TCS alone; As a result, Cara will discontinue its clinical program in ...
Cara Therapeutics Inc (NASDAQ: CARA) shares dive after as investors react to topline results from its KARE Phase 2 trial evaluating oral Korsuva (difelikefalin tablets) for the treatment of ...
La nueva normalidad es la piel atópica y muy sensible: te enseñamos a cuidarla como se merece.
Una semana de exámenes o una mala racha personal, y de repente, nuestra piel reacciona con rojeces y picor. Un estudio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results